# SERG Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/serg-technologies

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.sergtechnologies.com
- Total disclosed funding: $0.6M
- Latest round: Seed (Dec 13, 2019)
- Investors on record: 1

## About

SERG Technologies Limited develops innovative digital therapeutics and healthcare solutions aimed at improving the lives of individuals with neurodegenerative movement disorders, focusing particularly on Parkinson's Disease.Founded in 2019, SERG Technologies Limited is headquartered in London, UK, and operates in the healthcare technology sector, providing solutions for individuals with neurodegenerative conditions. The company has successfully raised GBP 1.6 million in its latest funding round on March 28, 2022, led by Mercia Asset Management, alongside other investors including Imperial College Business School, Newable, and Velocity.Partners. The total amount raised to date is GBP 1.6 million, with a current company valuation of GBP 5.328 million. The company has completed two deals so far.SERG Technologies specializes in digital therapeutics and healthcare solutions designed specifically for individuals living with neurodegenerative movement disorders, primarily Parkinson's Disease. Its flagship product, PD.Ignite, is an analytics platform integrating patented wearable technology with a user-friendly dashboard, enabling healthcare providers, patients, and caregivers to manage Parkinson's Disease effectively through personalized care plans. The company’s solutions primarily target healthcare professionals, research institutions, and patients in the United Kingdom, with plans for expansion into other European territories.SERG Technologies generates revenue primarily through its PD.Ignite platform, which is offered via a subscription-based model tailored for healthcare providers and institutions managing Parkinson's Disease. The company engages in strategic partnerships allowing for bulk licensing of its platform, facilitating widespread clinician and patient access. Revenue may also derive from collaborations with research institutions, potentially generating grants and funding from entities like Innovate UK and the National Institute of Health and Care Research.In March 2022, SERG Technologies raised GBP 1.6 million in venture funding to achieve regulatory approval for launching its PD.Ignite system in the UK and US markets. The company intends to utilize this funding to support the development of upcoming products designed to enhance patient care. Future strategies include expanding into additional European markets, with specific target regions to be determined as the company grows.

## Funding rounds

- Seed, Dec 13, 2019, $0.6M — Velocity.Partners

## Investors

- Velocity.Partners (https://capitalatlas.ai/funds/velocity-partners) — Seed